The Effects of Various Feed Forms and Dietary Supplements (Probiotic and Antibiotic) on Performance, Immune System, Cecal Microbiota, and Intestinal Morphology in Broiler Chickens

This study was conducted to evaluate the effects of feed form (FF) and dietary supplements on performance, immune system, cecal microflora, and intestinal morphology in broiler chickens. A total of 960 one-day-old Ross 308 mixed-sex chickens were distributed to 8 treatments consisting of 6 replicates (20 birds/pen). The experimental design was a 2×4 factorial arrangement of treatments evaluating two feed forms (mash or pellet) and dietary supplements [without a supplement, Lactobacillus acidophilus (L. acidophilus), Bacillus subtilus (B. subtilus), and Avilamycin (an antibiotic)]. Considering the main effects, dietary supplements and pellet diets significantly improved growth performance parameters (FI, BWG, and FCR) compared to the other treatments. Birds fed with a pellet diet had a reduced relative weight of the gizzard and pancreas, increased villus height, and gained the relative weight of the liver and small intestinal. Regardless of the FF, B. subtilis supplementation tended to greater villus height, lower crypt depth, and higher villus height to crypt depth ratio compared to other groups. Birds fed with mash diets supplemented with L. acidophilus and B. subtilis and a pelleted diet supplemented B. subtilis had higher villus height, goblet cell, and Lactobacillus population in the gut compared to the other treatments. Probiotics supplementation reduced the percentage of heterophils compared to other diets. The significant interaction between FF and dietary supplements showed that L. acidophilus in the mash diet tended to enhance the percentage of lymphocytes and reduce the heterophil to lymphocyte ratio compared to the pelleted diet. The main factors had no significant effect on anti-SRBC antibody titer. The results from this study indicated that the probiotic L. acidophilus and B. subtilis used in the mash diet may serve as alternatives to an antibiotic

Risk factors for late presentation of chronic glaucoma in an Iranian population

Purpose: To identify risk factors for late presentation in chronic glaucoma. Materials and Methods: In a hospital-based case-control study, 312 newly diagnosed consecutive patients with chronic glaucoma were recruited to study in Nikookari Hospital in Tabriz - Iran. Cases were defined as patients presenting with absolute field loss within 5° of fixation or a cup to disc ratio >0.8 in one or both eyes (188 patients). Controls were patients with no absolute field loss within 20° in either eye but otherwise glaucomatous field loss and a cup to disc ratio >0.5 or a difference of 0.2 or greater between the discs (124 patents). Results: In logistic regression model, there was a significant association between late presentation and male gender, lower education status, pseudoexfoliative glaucoma, high intraocular pressure (IOP) in the first presentation and no eye exam in last 2 years. Patients with pseudoexfoliative glaucoma had 1.5 times more odd for late presentation (1.52 confidence interval [CI]: 1.14-2.24 P = 0.004). Patients that visited by an ophthalmologist in the last 2 years had 0.5 less likely to present with advanced glaucoma (0.54 CI: 0.32-0.92 P = 0.025). Higher IOP in initial examination was associated with advanced glaucoma. We estimated 1.08 increase in odd (CI: 1.03-1.04 P = 0.001) per increase in 1 mmHg in IOPs above 25 mmHg. Conclusion: Our study shows that several risk factors present for late presentation in chronic glaucoma. Our results suggest planning screening programs in high-risk individuals for early detection of glaucoma and prevention of blindness

Optimization of operating parameters for efficient photocatalytic inactivation of Escherichia coli based on a statistical design of experiments

In this work, the individual and interaction effects of three key operating parameters of the photocatalytic disinfection process were evaluated and optimized using response surface methodology (RSM) for the first time. The chosen operating parameters were: reaction temperature, initial pH of the reaction mixture and TiO2 P-25 photocatalyst loading. Escherichia coli concentration, after 90 minutes irradiation of UV-A light, was selected as the response. Twenty sets of photocatalytic disinfection experiments were conducted by adjusting operating parameters at five levels using the central composite design. Based on the experimental data, a semi-empirical expression was established and applied to predict the response. Analysis of variance revealed a strong correlation between predicted and experimental values of the response. The optimum values of the reaction temperature, initial pH of the reaction mixture and photocatalyst loading were found to be 40.3°C, 5.9 g/L, and 1.0 g/L, respectively. Under the optimized conditions, E. coli concentration was observed to reduce from 107 to about 11 CFU/mL during the photocatalytic process. Moreover, all these results showed the great significance of the RSM in developing high performance processes for photocatalytic water disinfection

Reversible and irreversible deactivation of Cu-CHA NH3-SCRcatalysts by SO2 and SO3

Abstract Sulfur oxides are a common source for the deactivation of Cu-exchanged CHA zeolite based catalysts used for NOx reduction in diesel exhausts by selective catalytic reduction with NH3 (NH3-SCR). Since water and possible formation of SO3 affect the deactivation of Cu-CHA catalysts, the deactivation in the presence of SO2 or a mixture of SO2 and SO3 was studied by measuring the SCR activity in wet and dry gas at 200 and 550 °C. The estimated S-content in the catalysts before and after 4 h regeneration at 550 °C in NO, NH3, O2 and H2O was related to the deactivation. The deactivation can be divided into two parts: a reversible deactivation that is restored by the regeneration treatment, and an irreversible part. The irreversible deactivation does not affect the activation energy for NH3-SCR and display a 1:1 correlation with the S-content, consistent with deactivation by Cu-sulfate formation. The reversible deactivation results in a lower activation energy and a deactivation that is larger than expected from the S-content. The presence of SO3 at 200 °C leads to higher reversible and irreversible deactivation, but has no significant impact at 550 °C. Furthermore, the irreversible deactivation is always higher when exposed at 200 °C than at 550 °C, and in wet conditions, compared to a dry feed. The deactivation is predominantly reversible, making regeneration at 550 °C a realistic approach to handle S-poisoning in exhaust systems

Time to Conquer Fungal Infectious Diseases: Employing Nanoparticles as Powerful and Versatile Antifungal Nanosystems against a Wide Variety of Fungal Species

The development of novel antifungal agents and, in particular, the widespread use of these medications over the course of the past two decades, has had a significant impact on the treatment of fungal infectious diseases. This has resulted in a complete transformation of the treatment of fungal infectious diseases. However, the widespread development of antibiotic resistance has masked the significance of such breakthroughs. Antifungal infection treatment with nanoparticles has been shown to be effective. As a result of their unique characteristics, these substances, in contrast to antibiotics in their purest form, are able to exhibit an increased anti-proliferative capacity while requiring a lower concentration than traditional drugs do in order to achieve the same effect. Decreased drug effectiveness, minimal tissue penetration throughout tissue, restricted tissue penetration, decreased bioavailability, poor drug pharmacokinetics, and low water solubility are some of the major factors contributing to the employment of antifungal medicines in delivery systems. Because of this, one of the primary goals of incorporating antifungal medications into varying sorts of nanoparticles is to reduce the negative effects of the drugs’ inherent qualities. This article provides an overview of the many types of nanoparticles, such as metal, metal oxide, and non-metal oxide nanoparticles, carbon-based nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, solid lipid nanoparticles, nanofibers, antifungal peptides, composites, and ZnO quantum dots, that can be used as antifungal drug delivery systems, as well as the benefits that these nanomaterials have over purified medications